Shares of Intuitive Surgical Inc. ISRG shed 1.43% to $571.88 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.50% to 6,040 ...

Let's discuss whether Intuitive Surgical stock is a buy now. For more than two decades, the da Vinci surgical system has represented the industry standard for minimally invasive robotic-assisted ...

INTUITIVE SURGICAL, INC. (ISRG) is a large-cap growth stock in the Medical Equipment & Supplies industry. The rating using this strategy is 75% based on the firm’s underlying fundamentals and ...

The company’s stock is surging, having grown around 60% over the past 12 months. Its Q4 2024 results showed considerable growth, with Da Vinci procedures increasing by 18%. Intuitive Surgical ...

Leerink Partners’ price target would indicate a potential downside of 4.55% from the stock’s current price. A number of other equities research analysts also recently weighed in on ISRG.

The business model, with 84% recurring revenue from instruments, accessories, and services, ensures stable growth and high margins, despite occasional stock volatility. Financially, ISRG boasts ...

Intuitive Surgical (NASDAQ: ISRG) recently reported its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $2.4 billion and adjusted earnings of ...

Mizuho Securities analyst Anthony Petrone has maintained their neutral stance on ISRG stock, giving a Hold rating on January 24. Anthony Petrone has given his Hold rating due to a combination of ...

JPMorgan Chase & Co. currently has an overweight rating on the medical equipment provider’s stock. ISRG has been the topic of a number of other research reports. Leerink Partners raised their ...

The stock seemed to sell off because its 2025 guidance indicated a slowdown from last year. Intuitive Surgical expects procedure growth of 13% to 16%, which compared to the Wall Street consensus ...